» Articles » PMID: 34136474

Antimicrobial Activity of Human Fetal Membranes: From Biological Function to Clinical Use

Overview
Date 2021 Jun 17
PMID 34136474
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

The fetal membranes provide a supportive environment for the growing embryo and later fetus. Due to their versatile properties, the use of fetal membranes in tissue engineering and regenerative medicine is increasing in recent years. Moreover, as microbial infections present a crucial complication in various treatments, their antimicrobial properties are gaining more attention. The antimicrobial peptides (AMPs) are secreted by cells from various perinatal derivatives, including human amnio-chorionic membrane (hACM), human amniotic membrane (hAM), and human chorionic membrane (hCM). By exhibiting antibacterial, antifungal, antiviral, and antiprotozoal activities and immunomodulatory activities, they contribute to ensuring a healthy pregnancy and preventing complications. Several research groups investigated the antimicrobial properties of hACM, hAM, and hCM and their derivatives. These studies advanced basic knowledge of antimicrobial properties of perinatal derivatives and also provided an important insight into the potential of utilizing their antimicrobial properties in a clinical setting. After surveying the studies presenting assays on antimicrobial activity of hACM, hAM, and hCM, we identified several considerations to be taken into account when planning future studies and eventual translation of fetal membranes and their derivatives as antimicrobial agents from bench to bedside. Namely, (1) the standardization of hACM, hAM, and hCM preparation to guarantee rigorous antimicrobial activity, (2) standardization of the antimicrobial susceptibility testing methods to enable comparison of results between various studies, (3) investigation of the antimicrobial properties of fetal membranes and their derivatives in the setting, and (4) designation of donor criteria that enable the optimal donor selection. By taking these considerations into account, future studies will provide crucial information that will enable reaching the optimal treatment outcomes using the fetal membranes and their derivatives as antimicrobial agents.

Citing Articles

Determining Sex-Specific Gene Expression Differences in Human Chorion Trophoblast Cells.

Goncharov D, Lintao R, Urrabaz-Garza R, Radnaa E, Kammala A, Richardson L Int J Mol Sci. 2025; 26(5).

PMID: 40076861 PMC: 11900912. DOI: 10.3390/ijms26052239.


Characterization of Amnion-Derived Membrane for Clinical Wound Applications.

Ingraldi A, Allen T, Tinghitella J, Merritt W, Becker T, Tabor A Bioengineering (Basel). 2024; 11(10).

PMID: 39451330 PMC: 11504399. DOI: 10.3390/bioengineering11100953.


Synergistic effects of antimicrobial components of the human-derived composite amnion-chorion membrane on bacterial growth.

Brummerhop A, Lee C, Weltman R, Tribble G, van der Hoeven R, Chiu Y Front Cell Infect Microbiol. 2024; 14:1472737.

PMID: 39435187 PMC: 11491435. DOI: 10.3389/fcimb.2024.1472737.


PGRMC2 and HLA-G regulate immune homeostasis in a microphysiological model of human maternal-fetal membrane interface.

Lintao R, Richardson L, Kumar Kammala A, Chapa J, Yunque-Yap D, Khanipov K Commun Biol. 2024; 7(1):1041.

PMID: 39179795 PMC: 11344061. DOI: 10.1038/s42003-024-06740-2.


Amnion as an Innovative Antiseptic Carrier: A Comparison of the Efficacy of Allogeneic and Xenogeneic Transplantations in the Context of Burn Therapy.

Klama-Baryla A, Sitkowska A, Labus W, Strzelec P, Kraut M, Smetek W Medicina (Kaunas). 2024; 60(6).

PMID: 38929632 PMC: 11206031. DOI: 10.3390/medicina60061015.


References
1.
Koizumi N, Inatomi T, Sotozono C, Fullwood N, Quantock A, Kinoshita S . Growth factor mRNA and protein in preserved human amniotic membrane. Curr Eye Res. 2000; 20(3):173-7. View

2.
Bryant-Greenwood G . The extracellular matrix of the human fetal membranes: structure and function. Placenta. 1998; 19(1):1-11. DOI: 10.1016/s0143-4004(98)90092-3. View

3.
Yarbrough V, Winkle S, Herbst-Kralovetz M . Antimicrobial peptides in the female reproductive tract: a critical component of the mucosal immune barrier with physiological and clinical implications. Hum Reprod Update. 2014; 21(3):353-77. DOI: 10.1093/humupd/dmu065. View

4.
Para R, Romero R, Miller D, Panaitescu B, Varrey A, Chaiworapongsa T . Human β-defensin-3 participates in intra-amniotic host defense in women with labor at term, spontaneous preterm labor and intact membranes, and preterm prelabor rupture of membranes. J Matern Fetal Neonatal Med. 2019; 33(24):4117-4132. PMC: 6800590. DOI: 10.1080/14767058.2019.1597047. View

5.
Farhadihosseinabadi B, Farahani M, Tayebi T, Jafari A, Biniazan F, Modaresifar K . Amniotic membrane and its epithelial and mesenchymal stem cells as an appropriate source for skin tissue engineering and regenerative medicine. Artif Cells Nanomed Biotechnol. 2018; 46(sup2):431-440. DOI: 10.1080/21691401.2018.1458730. View